Why was edrophonium discontinued? The Reasons Behind the Tensilon Test's End
•
3 min read
In 2018, the U.S. Food and Drug Administration (FDA) discontinued the use of edrophonium, effectively ending the era of the Tensilon test as a diagnostic tool for myasthenia gravis. This decision was driven by the test's inherent limitations and the advent of safer, more accurate diagnostic methods.
